JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8463 Lithocholic Acid

Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)

Summary: Toxic secondary bile acid; induces intrahepatic cholestasis; FXR antagonist and PXR/SXR agonist

insoluble in H2O; ≥12.95 mg/mL
A8498 Pentamidine

Summary: Drug to treat protozoal diseases

insoluble in EtOH; ≥13.5 mg/mL
A8471 Meticrane

Summary: Peripheral-type benzodiazepine receptor (PBR) inhibitor

insoluble in H2O; insoluble in EtOH; ≥12.45 mg/mL
A2700 10Panx
1 Citation

Target: Gap Junctions

Summary: Panx-1 mimetic inhibitor

≥124.2 mg/mL
B4106 4SC-202

Summary: Class I HDAC inhibitor
B6288 Spaglumic acid

Summary: mGlu3 receptor agonist and NMDA receptor activator
B6329 Dantrolene, sodium salt

Summary: ryanodine receptor (RYR) channels inhibitor

insoluble in EtOH; insoluble in H2O; ≥12.2 mg/mL
B6523 Spermidine trihydrochloride

Target: NMDA Receptors

Summary: A NMDA receptor agonist

insoluble in DMSO; insoluble in EtOH; ≥10 mg/mL
B7005 Prostaglandin E2
2 Citation

Target: Prostaglandin EP receptors

Summary: Endogenous prostaglandin

≥35.2 mg/mL
B7587 Puromycin dihydrochloride
21 Citation

Summary: Puromycin dihydrochloride

≥27.2 mg/mL